Loading
Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Latest filing published 15 Sept 2026 for RenovoRx, Inc..
Insider track record
Disclosed buys
1
Disclosed sells
0
Signal history
No signal scores available.
Closed purchases
Market purchases
1
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Mark Voll: trading record in brief
Mark Voll appears in our data through filings on RenovoRx, Inc. shares, published by SEC (Form 4). Between 20 March 2026 and 10 September 2026, the trades on record add up to 4 filings.
No open-market sale appears; the market trades are 1 purchase. No amount is published for 1 filing, which the totals therefore leave out. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Outside the open market, there are 3 share grants.
The newest entry dates from 15 September 2026: a share grant, in RenovoRx, Inc. The most recent open-market purchase was published on 24 March 2026, 214 days ago. The median gap between a trade and its publication by SEC (Form 4) is 4 days. Section 16 rules allow two business days to file each Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Mark Voll
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations4 total
80,000 shares0Common StockSEC:0001493152-26-042650:0
80,000 shares0Common StockSEC:0001493152-26-015593:0
12,380 shares0Common StockSEC:0001493152-26-013083:0
97,200 sharesCommon StockSEC:0001493152-26-012481:0
Canonical exit: 18 Jun 2026 (T+90)
4 of 4 declarations
